Demplatin pegraglumer Terminated Phase 1 Trials for Head and Neck Neoplasms Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02817113Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer